Parasite biomass and microvasculature obstruction are strongly associated with disease severity and death in Plasmodium falciparum-infected humans. This is related to sequestration of mature, blood-stage parasites (schizonts) in peripheral tissue. The prevailing view is that schizont sequestration leads to an increase in pathogen biomass, yet direct experimental data to support this are lacking. Here, we first studied parasite population dynamics in inbred wild-type (WT) mice infected with the rodent species of malaria, Plasmodium berghei ANKA. As is commonly reported, these mice became moribund due to large numbers of parasites in multiple tissues. We then studied infection dynamics in a genetically targeted line of mice, which displayed minimal tissue accumulation of parasites. We constructed a mathematical model of parasite biomass dynamics, incorporating schizontspecific host clearance, both with and without schizont sequestration. Combined use of mathematical and in vivo modeling indicated, first, that the slowing of parasite growth in the genetically targeted mice can be attributed to specific clearance of schizonts from the circulation and, second, that persistent parasite growth in WT mice can be explained solely as a result of schizont sequestration. Our work provides evidence that schizont sequestration could be a major biological process driving rapid, early increases in parasite biomass during blood-stage Plasmodium infection.
Malaria caused approximately 1,238,000 deaths worldwide in 2010 (1). Of the five different Plasmodium species that infect humans, Plasmodium falciparum is associated with greatest morbidity (2, 3). Parasite biomass and microvasculature obstruction are among the most reliable prognostic indicators in P. falciparum-infected humans, with high levels of either indicator being strongly associated with severe disease and negative outcome (4-6). High P. falciparum biomass could in theory result from poor clearance of freely circulating parasites by the host's mononuclear phagocytic system (MPS), principally macrophages in the spleen and liver. Clinical studies, including ex vivo perfusion of human spleens and analyses of splenectomized malaria patients, argue that humans can clear at least a proportion of circulating P. falciparum parasites (7-11). Furthermore, increased rigidity of red blood cells (RBCs) infected with P. falciparum parasites, particularly mature-stage trophozoites and schizonts, appears to render them less capable of passage through the spleen than either uninfected RBCs or ring-stage P. falciparum-infected RBCs (P. falciparum-iRBCs) (12). Thus, the human MPS can clear circulating mature P. falciparum-iRBCs, but its competency at doing so in vivo remains unclear. A mechanism that could facilitate increases in parasite biomass is evasion of the host MPS by sequestration of P. falciparum-iRBCs in peripheral tissues. A large body of literature has clearly identified P. falciparum-expressed ligands, which mediate adherence of schizont-and late-stage trophozoite-iRBCs to ...